The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Endothelin Receptor Antagonist Market Research Report 2025

Global Endothelin Receptor Antagonist Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1722412

No of Pages : 88

Ask Your Query

Synopsis
The global Endothelin Receptor Antagonist market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global companies of Endothelin Receptor Antagonist include Gilead Sciences Inc., Glaxosmithkline Inc., Sun Pharmaceutical Industries, Inc., Mylan Pharmaceuticals Inc. and Actavis Pharma, Inc., etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Ambrisentan, which accounted for % of the global market of Endothelin Receptor Antagonist in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Endothelin Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endothelin Receptor Antagonist.
The Endothelin Receptor Antagonist market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Endothelin Receptor Antagonist market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endothelin Receptor Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Gilead Sciences Inc.
  • Glaxosmithkline Inc.
  • Sun Pharmaceutical Industries, Inc.
  • Mylan Pharmaceuticals Inc.
  • Actavis Pharma, Inc.

Product Type Insights
Global markets are presented by Endothelin Receptor Antagonist type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Endothelin Receptor Antagonist are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Endothelin Receptor Antagonist segment by Type

  • Ambrisentan
  • Bosentan
  • Macitentan

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Endothelin Receptor Antagonist market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Endothelin Receptor Antagonist market.

Endothelin Receptor Antagonist Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Mail Order Pharmacy

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Endothelin Receptor Antagonist market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endothelin Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Endothelin Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Endothelin Receptor Antagonist industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endothelin Receptor Antagonist.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endothelin Receptor Antagonist companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endothelin Receptor Antagonist Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Ambrisentan
1.2.3 Bosentan
1.2.4 Macitentan
1.3 Market by Application
1.3.1 Global Endothelin Receptor Antagonist Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Mail Order Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endothelin Receptor Antagonist Market Perspective (2017-2028)
2.2 Endothelin Receptor Antagonist Growth Trends by Region
2.2.1 Endothelin Receptor Antagonist Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Endothelin Receptor Antagonist Historic Market Size by Region (2017-2022)
2.2.3 Endothelin Receptor Antagonist Forecasted Market Size by Region (2023-2028)
2.3 Endothelin Receptor Antagonist Market Dynamics
2.3.1 Endothelin Receptor Antagonist Industry Trends
2.3.2 Endothelin Receptor Antagonist Market Drivers
2.3.3 Endothelin Receptor Antagonist Market Challenges
2.3.4 Endothelin Receptor Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endothelin Receptor Antagonist Players by Revenue
3.1.1 Global Top Endothelin Receptor Antagonist Players by Revenue (2017-2022)
3.1.2 Global Endothelin Receptor Antagonist Revenue Market Share by Players (2017-2022)
3.2 Global Endothelin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endothelin Receptor Antagonist Revenue
3.4 Global Endothelin Receptor Antagonist Market Concentration Ratio
3.4.1 Global Endothelin Receptor Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endothelin Receptor Antagonist Revenue in 2021
3.5 Endothelin Receptor Antagonist Key Players Head office and Area Served
3.6 Key Players Endothelin Receptor Antagonist Product Solution and Service
3.7 Date of Enter into Endothelin Receptor Antagonist Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endothelin Receptor Antagonist Breakdown Data by Type
4.1 Global Endothelin Receptor Antagonist Historic Market Size by Type (2017-2022)
4.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2023-2028)
5 Endothelin Receptor Antagonist Breakdown Data by Application
5.1 Global Endothelin Receptor Antagonist Historic Market Size by Application (2017-2022)
5.2 Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Endothelin Receptor Antagonist Market Size (2017-2028)
6.2 North America Endothelin Receptor Antagonist Market Size by Country (2017-2022)
6.3 North America Endothelin Receptor Antagonist Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endothelin Receptor Antagonist Market Size (2017-2028)
7.2 Europe Endothelin Receptor Antagonist Market Size by Country (2017-2022)
7.3 Europe Endothelin Receptor Antagonist Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endothelin Receptor Antagonist Market Size (2017-2028)
8.2 Asia-Pacific Endothelin Receptor Antagonist Market Size by Country (2017-2022)
8.3 Asia-Pacific Endothelin Receptor Antagonist Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endothelin Receptor Antagonist Market Size (2017-2028)
9.2 Latin America Endothelin Receptor Antagonist Market Size by Country (2017-2022)
9.3 Latin America Endothelin Receptor Antagonist Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endothelin Receptor Antagonist Market Size (2017-2028)
10.2 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2017-2022)
10.3 Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Gilead Sciences Inc.
11.1.1 Gilead Sciences Inc. Company Detail
11.1.2 Gilead Sciences Inc. Business Overview
11.1.3 Gilead Sciences Inc. Endothelin Receptor Antagonist Introduction
11.1.4 Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022)
11.1.5 Gilead Sciences Inc. Recent Development
11.2 Glaxosmithkline Inc.
11.2.1 Glaxosmithkline Inc. Company Detail
11.2.2 Glaxosmithkline Inc. Business Overview
11.2.3 Glaxosmithkline Inc. Endothelin Receptor Antagonist Introduction
11.2.4 Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022)
11.2.5 Glaxosmithkline Inc. Recent Development
11.3 Sun Pharmaceutical Industries, Inc.
11.3.1 Sun Pharmaceutical Industries, Inc. Company Detail
11.3.2 Sun Pharmaceutical Industries, Inc. Business Overview
11.3.3 Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Introduction
11.3.4 Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022)
11.3.5 Sun Pharmaceutical Industries, Inc. Recent Development
11.4 Mylan Pharmaceuticals Inc.
11.4.1 Mylan Pharmaceuticals Inc. Company Detail
11.4.2 Mylan Pharmaceuticals Inc. Business Overview
11.4.3 Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Introduction
11.4.4 Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022)
11.4.5 Mylan Pharmaceuticals Inc. Recent Development
11.5 Actavis Pharma, Inc.
11.5.1 Actavis Pharma, Inc. Company Detail
11.5.2 Actavis Pharma, Inc. Business Overview
11.5.3 Actavis Pharma, Inc. Endothelin Receptor Antagonist Introduction
11.5.4 Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022)
11.5.5 Actavis Pharma, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Endothelin Receptor Antagonist Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Ambrisentan
Table 3. Key Players of Bosentan
Table 4. Key Players of Macitentan
Table 5. Global Endothelin Receptor Antagonist Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Endothelin Receptor Antagonist Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Endothelin Receptor Antagonist Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Endothelin Receptor Antagonist Market Share by Region (2017-2022)
Table 9. Global Endothelin Receptor Antagonist Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Endothelin Receptor Antagonist Market Share by Region (2023-2028)
Table 11. Endothelin Receptor Antagonist Market Trends
Table 12. Endothelin Receptor Antagonist Market Drivers
Table 13. Endothelin Receptor Antagonist Market Challenges
Table 14. Endothelin Receptor Antagonist Market Restraints
Table 15. Global Endothelin Receptor Antagonist Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Endothelin Receptor Antagonist Market Share by Players (2017-2022)
Table 17. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2021)
Table 18. Ranking of Global Top Endothelin Receptor Antagonist Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Endothelin Receptor Antagonist Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endothelin Receptor Antagonist Product Solution and Service
Table 22. Date of Enter into Endothelin Receptor Antagonist Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endothelin Receptor Antagonist Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2017-2022)
Table 26. Global Endothelin Receptor Antagonist Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Endothelin Receptor Antagonist Revenue Market Share by Type (2023-2028)
Table 28. Global Endothelin Receptor Antagonist Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2017-2022)
Table 30. Global Endothelin Receptor Antagonist Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Endothelin Receptor Antagonist Revenue Market Share by Application (2023-2028)
Table 32. North America Endothelin Receptor Antagonist Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Endothelin Receptor Antagonist Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Endothelin Receptor Antagonist Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Endothelin Receptor Antagonist Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Endothelin Receptor Antagonist Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Endothelin Receptor Antagonist Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Endothelin Receptor Antagonist Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Endothelin Receptor Antagonist Market Size by Country (2023-2028) & (US$ Million)
Table 42. Gilead Sciences Inc. Company Detail
Table 43. Gilead Sciences Inc. Business Overview
Table 44. Gilead Sciences Inc. Endothelin Receptor Antagonist Product
Table 45. Gilead Sciences Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022) & (US$ Million)
Table 46. Gilead Sciences Inc. Recent Development
Table 47. Glaxosmithkline Inc. Company Detail
Table 48. Glaxosmithkline Inc. Business Overview
Table 49. Glaxosmithkline Inc. Endothelin Receptor Antagonist Product
Table 50. Glaxosmithkline Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022) & (US$ Million)
Table 51. Glaxosmithkline Inc. Recent Development
Table 52. Sun Pharmaceutical Industries, Inc. Company Detail
Table 53. Sun Pharmaceutical Industries, Inc. Business Overview
Table 54. Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Product
Table 55. Sun Pharmaceutical Industries, Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022) & (US$ Million)
Table 56. Sun Pharmaceutical Industries, Inc. Recent Development
Table 57. Mylan Pharmaceuticals Inc. Company Detail
Table 58. Mylan Pharmaceuticals Inc. Business Overview
Table 59. Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Product
Table 60. Mylan Pharmaceuticals Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022) & (US$ Million)
Table 61. Mylan Pharmaceuticals Inc. Recent Development
Table 62. Actavis Pharma, Inc. Company Detail
Table 63. Actavis Pharma, Inc. Business Overview
Table 64. Actavis Pharma, Inc. Endothelin Receptor Antagonist Product
Table 65. Actavis Pharma, Inc. Revenue in Endothelin Receptor Antagonist Business (2017-2022) & (US$ Million)
Table 66. Actavis Pharma, Inc. Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endothelin Receptor Antagonist Market Share by Type: 2021 VS 2028
Figure 2. Ambrisentan Features
Figure 3. Bosentan Features
Figure 4. Macitentan Features
Figure 5. Global Endothelin Receptor Antagonist Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Mail Order Pharmacy Case Studies
Figure 9. Endothelin Receptor Antagonist Report Years Considered
Figure 10. Global Endothelin Receptor Antagonist Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Endothelin Receptor Antagonist Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Endothelin Receptor Antagonist Market Share by Region: 2021 VS 2028
Figure 13. Global Endothelin Receptor Antagonist Market Share by Players in 2021
Figure 14. Global Top Endothelin Receptor Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Receptor Antagonist as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Endothelin Receptor Antagonist Revenue in 2021
Figure 16. North America Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Endothelin Receptor Antagonist Market Share by Country (2017-2028)
Figure 18. United States Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Endothelin Receptor Antagonist Market Share by Country (2017-2028)
Figure 22. Germany Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Endothelin Receptor Antagonist Market Share by Region (2017-2028)
Figure 30. China Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Endothelin Receptor Antagonist Market Share by Country (2017-2028)
Figure 38. Mexico Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Endothelin Receptor Antagonist Market Share by Country (2017-2028)
Figure 42. Turkey Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Endothelin Receptor Antagonist Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Gilead Sciences Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2017-2022)
Figure 45. Glaxosmithkline Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2017-2022)
Figure 46. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2017-2022)
Figure 47. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2017-2022)
Figure 48. Actavis Pharma, Inc. Revenue Growth Rate in Endothelin Receptor Antagonist Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock